Table 4.
Summary of magnetic liquids biocompatibility.
Magnetic liquids | Concentrations | pH | Cell type | Short-term viability | Long-term proliferation | References |
---|---|---|---|---|---|---|
Gd·DTPA | 0, 4, 40, and 200 mm | 7.2 | NIH 3T3 cells/ Saccharomyces cerevisiae | Survived and grew over 2 d at 40 mm/ Viability was similar at all concentrations | 0-40 mm didn't inhibit the cell growth/ 40 and 200 mm inhibit cell division | [31] |
Gd·DTPA | 39, 79 and 240 mm | NA | HaCaT cells | 90% at 39 mm and 87% at 79 mm after 3 h, died at 240 mm | NA | [20] |
Gd·BOPTA/Gd·DOTA/Gd·HP·DO3A | 0, 10, 25, 50, 85, and 100 mm | NA | Jurkat cells | ∼40% on 1st d at 100 mm/∼75% on 1st d at 100 mm/>90% on 1st d at all concentrations | 25-100 mm inhibited the cell division/Cells proliferated normally below 25 mm/Cells proliferated almost normally at all concentrations | [96] |
Gd solution | 0, 30, 50, and 100 mm | Neutral | JH-EsoAd1 cells | ∼100% at all concentrations on 1st d | Maintained normal proliferation rates over 5 d | [43] |
1 BSA coated ferrofluid | 0, 15, 30, and 45 mg mL-1 | NA | HUVECs | >95% at all concentrations up to 2 h | Maintained normal proliferation rates (to confluence) | [25] |
1 Citrate stabilized ferrofluid | 0, 20, 40, 50, 60, 80, and 100 mm | 7.4 | Red blood cells | 75% | NA | [24] |
1 Graft copolymer functionalized ferrofluid | 0.30%, 0.79%, and 1.03% v/v | 6.8 | Red blood cells/ HeLa cells | 100 % at all concentrations up to 2 h/ ∼90 at all concentrations up to 2 h | NA | [65] |
2 EMG 408 ferrofluid | 1.1% v/v | ∼7 | Escherichia coli/ Saccharomyces cerevisiae | Remained almost unchanged viability over 2 d | NA | [30] |
2 EMG 408 ferrofluid | 0.3% v/v | ∼7 | Saccharomyces cerevisiae | 10% reduction in the number of cells over 24-48 h | NA | [67], [71], [73] |
Custom-made ferrofluids and
commercially available from Ferrotec Corporation.